PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of stemcellresBioMed CentralBiomed Central Web Sitesearchsubmit a manuscriptregisterthis articleStem Cell Research & TherapyJournal Front Page
 
Stem Cell Res Ther. 2017; 8: 195.
Published online 2017 September 19. doi:  10.1186/s13287-017-0647-6
PMCID: PMC5606035

Adipose-derived stem cell-released osteoprotegerin protects cardiomyocytes from reactive oxygen species-induced cell death

Abstract

Background

The paracrine effect is likely the major mechanism of the adipose-derived stem cell (ASC)-mediated cardioprotective effect. However, the exact composition and nature of ASC-released paracrine factors remain elusive. In the present study, we examined the effect of osteoprotegerin (OPG), a stem cell-released decoy receptor for death ligand, on the survival of cardiomyocytes exposed to oxidative stress.

Methods

The production of OPG from ASCs under oxidative stress was determined by ELISA and immunohistochemistry. The effects of OPG and the OPG-containing conditioned media of ASCs on the survival of cardiomyocytes were determined using a cell viability assay.

Results

Hydrogen peroxide (H2O2) significantly increased OPG production from ASCs in vitro, and OPG production from the ASCs transplanted into the ischemia–reperfusion-injured heart was also observed. OPG significantly attenuated cardiomyocyte death in vitro. OPG-containing conditioned media of ASCs also significantly protected cardiomyocytes. Delivery of siRNA specific to OPG significantly decreased the OPG production of ASCs, and also offset the protective effect of the conditioned media of ASCs.

Conclusions

Our study strongly suggests that OPG is one of the prosurvival factors released from ASCs that may contribute to the ASC-mediated cardioprotection and calls for further studies to elucidate detailed underlying mechanisms.

Electronic supplementary material

The online version of this article (doi:10.1186/s13287-017-0647-6) contains supplementary material, which is available to authorized users.

Keywords: Osteoprotegerin, Oxidative stress, Cardiomyocyte survival, Stem cell

Background

Previous studies have reported the cardioprotective effect of adipose-derived stem cells (ASCs) [1, 2]. Evidence suggests that the regenerative effect of transplanted stem cells is mainly mediated by paracrine factors [3, 4], and stem cell-released factors varied depending on the source of stem cells and the stimuli they were exposed to [5, 6]. Therefore, it is important to identify soluble factors contributing to the beneficial effect (i.e., host cell protection) of stem cells under a specified condition because a clinically effective stem cell-based therapeutic strategy can be developed based on such information. Osteoprotegerin (OPG) is known to be produced by stem cells, fibroblasts, and endothelial cells [7]. OPG is a soluble decoy receptor that binds to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), thereby neutralizing TRAIL-mediated apoptotic signaling [8]. TRAIL initiates signaling cascade by binding to corresponding receptors such as TRAIL-R1, TRAIL-R2, TRAIL-R3, and TRAIL-R4 [9]. TRAIL-R1 and TRAIL-R2 can promote cell death signaling cascades, while TRAIL-R3 and TRAIL-R4 antagonize the TRAIL-R1 and TRAIL-R2-mediated apoptotic signaling by competitively binding to TRAIL [10]. In the present study, we examined the effect of OPG on the survival of cardiomyocytes exposed to oxidative stress.

Methods

Culture of ASCs and H9c2 cells

Four vials of ASCs from four different human donors (StemPro human adipose-derived stem cells) were purchased from Invitrogen (Carlsbad, CA, USA), and rat cardiomyoblast cell line H9c2 cells were purchased from ATCC (Manassas, VA, USA). ASCs and H9c2 cells were maintained according to the manufacturer’s instructions. We used low-glucose Dulbecco’s modified Eagle’s medium (DMEM; Gibco, Waltham, MA, USA) and high-glucose DMEM (Gibco) containing 10% fetal bovine serum (FBS; Gibco) and 1% penicillin–streptomycin (Gibco) for ASCs and H9c2 cells, respectively.

Isolation rat neonatal ventricular cardiomyocytes

All experimental procedures for animal studies were approved by the committee for the care and use of laboratory animals of Catholic Kwandong University, and were performed in accordance with the committee’s guidelines and regulations (CKU01-2015-003-1). Neonatal rat ventricular cardiomyocytes were isolated and purified by enzymatic methods following a protocol published previously [11].

Ischemia–reperfusion injury and transplantation of ASCs

Male 8-week-old Sprague–Dawley rats (250 g) were used. The animals were put under anesthesia with zoletil (30 mg/kg) and xylazine (10 mg/kg). The left anterior descending coronary artery was occluded using a 6-0 silk suture (Johnson & Johnson, New Brunswick, NJ, USA). After 60 min of occlusion, the left anterior descending coronary artery was released for reperfusion, followed by cell transplantation. For transplantation, 1 × 106 cells were suspended in 30 μl PBS and injected to border zone using a 0.3-ml insulin syringe (BD Pharmingen, Franklin Lakes, NJ, USA).

Statistical analyses

Quantitative data were expressed as the means ± SD of at least three independent experiments. For statistical analysis, one-way ANOVA with Bonferroni correction was performed using OriginPro 8 SR4 software (version 8.0951; OriginLab Corporation, Northampton, MA, USA) if there were more than three groups. p < 0.05 was considered statistically significant.

Additional methods are available in Additional file 1.

Results

Hydrogen peroxide induced apoptosis of cardiomyocytes

Hydrogen peroxide (H2O2), a member of endogenous reactive oxygen species (ROS), has been used to simulate oxidative stress [12, 13]. When H9c2 and primary cultured rat cardiomyocytes were treated with increasing concentration of H2O2 for 48 hours, the viability of both H9c2 (Additional file 2: Figure S1A) and primary (Additional file 2: Figure S1B) cardiomyocytes significantly decreased with H2O2 at a concentration of 100 μM or higher. However, primary cardiomyocytes were more resistant to ROS than H9c2 cardiomyocytes. Therefore, we mainly used H9c2 cardiomyocytes, which have been used as an alternative to primary cultured cardiomyocytes [14], to clearly demonstrate the prosurvival effect of OPG.

To confirm that the H2O2-induced cell death was oxidative stress mediated, the cells were pretreated with the well-established antioxidant N-acetyl-l-cystein (NAC) [15]. NAC pretreatment attenuated H2O2-induced activation of caspase 3 and 8 (Additional file 2: Figure S1C) and also significantly attenuated H2O2-induced decrease of H9c2 viability (Additional file 2: Figure S1D). Furthermore, NAC pretreatment decreased the number of apoptotic propidium iodide (PI)/Annexin V double-stained cells [16] (Additional file 2: Figure S1E). Interestingly, H2O2 concentration up to 200 μM did not decrease the viability of ASCs (Additional file 3: Figure S2).

Oxidative stress increased OPG production from ASCs

Both H2O2 and TGF-β1, another soluble factor commonly present in damaged heart [17], significantly increased the OPG production of ASCs without decreasing viability (Fig. 1a). Also, H2O2 significantly increased mRNA expression of OPG and TRAIL receptor 3 (TRAIL-R3) (Additional file 4: Figure S3), which attenuates TRAIL-induced apoptosis [18]. In the ischemia–reperfusion (I/R)-injured heart without ASC transplantation, OPG expression was marginal only at day 1 after I/R injury (Fig. 1b). However, in the ASC transplantation group, prominent OPG expression was observed in the vicinity of transplanted ASCs, which gradually decreased with time (Fig. 1c).

Fig. 1
Oxidative stress induced OPG secretion from ACSs. (a) Amount of OPG secreted from ASCs exposed to H2O2 (100 μM) determined using an ELISA kit specific to human OPG. Conditioned media of ASCs exposed to H2O2 up to 48 hours were ...

OPG protected cardiomyocytes from ROS-induced cell death

To examine the effect of OPG on cardiomyocyte viability under oxidative stress, the cells were exposed to H2O2 with or without OPG (1.5 and 3 ng/ml) treatment. OPG treatment significantly protected from H2O2 (Fig. 2a) and suppressed activation of caspase 8 without affecting the expression of TRAIL-R2 (Fig. 2b). Both ASC conditioned media with or without 48 hours of H2O2 (100 μM) conditioning (designated as H2O2CM and NorCM, respectively) significantly attenuated H2O2-induced decrease of viability in both H9c2 (Fig. 2c) and primary (Fig. 2d) cardiomyocytes. Between NorCM and H2O2CM, H2O2CM was more effective to prevent H2O2-induced cardiomyocyte death.

Fig. 2
OPG protected cardiomyocytes from ROS-induced cell death. (a) Effect of OPG on H2O2-induced cell death of H9c2 examined using a cell counting kit. H9c2 cells were treated with 100 μM of H2O2 for 24 hours with or without OPG (1.5 ...

Downregulation of OPG offset cell protective effect of ASC conditioned media

To validate whether the cell protective effect of the ASC conditioned media was OPG mediated, siRNA specific to OPG was utilized. Delivery of OPG-specific siRNA to ASCs significantly attenuated OPG mRNA expression (Fig. 3a) and decreased OPG production (Fig. 3b). OPG-specific siRNA had no negative effect on the cell viability of ASCs (Fig. 3c). However, when siRNA specific to TRAIL-R3 was codelivered with OPG-specific siRNA, the viability of ASCs significantly decreased (Additional file 5: Figure S4). Finally, H2O2CM obtained from OPG-specific siRNA-treated ASCs showed decreased protective effect on cardiomyocytes exposed to H2O2 (Fig. 3d).

Fig. 3
Downregulation of OPG offset protective effect of ASC conditioned media. (a) OPG-siRNA-mediated downregulation of OPG in H2O2-treated ASCs. ASCs were transfected with 20 nM of OPG-specific siRNA for 24 hours, and then exposed to 100 μM ...

Discussion

It has been reported that TRAIL was released from the postischemic heart soon after the onset of reperfusion [19]. Considering ROS production, a major cause of myocardial cell death in I/R injury [20], is an early event in myocardial reperfusion injury, TRAIL released at the onset of reperfusion may by associated with increased ROS and subsequent myocardial cell death in the I/R-injured heart. Therefore, we hypothesized that ASCs transplanted into damaged heart (i.e., I/R-injured heart where excessive oxidative stress causes cardiac cell death [2123]) secrete OPG, and in turn the ASC-released OPG prevents host cardiomyocyte death by antagonizing TRAIL signaling, which has never been tested.

To test the hypothesis in vitro, we used 100 μM of H2O2 to simulate oxidative stress to which both host cardiomyocytes and transplanted ASCs are exposed in vivo. In our study, H2O2 induced cardiomyocyte death via oxidative stress-mediated activation of apoptosis, confirming the validity of our experimental setting (Additional file 2: Figure S1). When ASCs were exposed to H2O2 or transplanted to I/R-injured heart, the production of OPG was significantly increased (Fig. 1), suggesting that ASCs exposed to a hostile microenvironment, such as I/R-injured heart, can produce OPG for the first few days following transplantation. Further experiments showed that OPG can suppress ROS-induced apoptosis of cardiomyocytes (Fig. 2a, b) and demonstrated that H2O2 conditioning of ASCs enhanced the protective effect of conditioned media possibly by increasing OPG production from ASCs (Fig. 2c, d). Experiments using OPG-specific siRNA indicated that the cell protective effect of ASC conditioned media was indeed OPG mediated (Fig. 3).

One interesting observation was that ASCs were less sensitive to H2O2 compared to cardiomyocytes (Additional file 3: Figure S2). This might have something to do with the increased OPG and TRAIL-R3 expression under oxidative stress (Additional file 4: Figure S3) because cotransfection of siRNAs specific to OPG and TRAIL-R3 significantly decreased the viability of ASCs exposed to H2O2 (Additional file 5: Figure S4). This also suggested that OPG and TRAIL-R3 may compensate each other in terms of suppressing TRAIL-mediated cell death in ASCs. Nevertheless, without any further experimental evidence, this can only be speculated at this point. We are currently working to elucidate more detailed underlying mechanisms of OPG-mediated cardiomyocyte protection and to validate and confirm the findings of this study in vivo for further studies.

Conclusion

In the present study we provided evidence that OPG is an ASC-released soluble factor that can protect cardiomyocytes from ROS-induced apoptosis for the first time. The results of this study warrant further studies to fully elucidate the exact nature of stem cell-released paracrine factors and may help us to design an effective stem cell-based therapeutic strategy in the future.

Additional files

Additional file 1:(35K, docx)

Describes additional methods including primers used for RT-PCR. (DOCX 34 kb)

Additional file 2:(238K, pdf)

Figure S1. Showing ROS-induced cardiomyocyte death. (A) Viability of H9c2 cardiomyocytes exposed to increasing concentration of H2O2 for 24 hours. *p < 0.05 compared to untreated control. (B) Effect of H2O2 on viability of primary cardiomyocytes. *p < 0.05 compared to untreated control. (C) Expression of activated (cleaved) caspase 3 and 8 in H9c2 cardiomyocytes exposed to H2O2 (100 μM) for 24 hours with or without antioxidant N-acetyl-l-cystein (NAC) (1.5 mM). (D) Viability of H9c2 cardiomyocytes exposed to H2O2 (100 μM) for 24 hours with or without antioxidant NAC (1.5 mM). *p < 0.05. (E) Flow cytometry analysis of H9c2 cardiomyocytes exposed to H2O2 (100 μM) for 24 hours with or without antioxidant NAC (1.5 mM). PI propidium iodide. (PDF 237 kb)

Additional file 3:(36K, pdf)

Figure S2. Showing effect of H2O2 on ASC viability. *p < 0.05 compared to control. (PDF 36 kb)

Additional file 4:(160K, pdf)

Figure S3. Showing ROS-induced OPG and TRAIL-R3 expression in ASCs. *p < 0.05 compared to corresponding control of each group. (PDF 160 kb)

Additional file 5:(88K, pdf)

Figure S4. Showing that OPG and TRAIL-R3 contribute to the survival of ASCs exposed to ROS. (A) Expression of TRAIL-R3 mRNA 24 hours after transfection of siRNA specific to TRAIL-R3. 18 s-rRNA used as internal control. (B) Effect of OPG and/or TRAIL-R3 downregulation on the viability of ASCs exposed ROS. Cells transfected with OPG siRNA and/or TRAIL-R3 siRNA for 24 hours and then exposed to H2O2 (100 and 200 μM) for an additional 24 hours. *p < 0.05 compared to untreated control. (PDF 87 kb)

Acknowledgements

Not applicable.

Funding

This study was supported by grants funded by the Korea Ministry of Science, ICT and Future Planning (NRF-2011-0019254 and NRF-2015M3A9E6029519) and a grant from the Korea Health 21 R&D Project, Ministry of Health & Welfare, Republic of Korea (A120478).

Availability of data and materials

All data supporting the conclusions of this article are included within the article and its supplementary files.

Abbreviations

ASC
Adipose-derived stem cell
DMEM
Dulbecco’s modified Eagle’s medium
ELISA
Enzyme-linked immunosorbent assay
FBS
Fetal bovine serum
H2O2CM
ASC conditioned media with H2O2 conditioning
I/R
Ischemia–reperfusion
NAC
N-acetylcystein
NorCM
ASC conditioned media without H2O2 conditioning
OPG
Osteoprotegerin
PBS
Phosphate-buffered saline
ROS
Reactive oxygen species
TGF-β1
Transforming growth factor beta 1
TNF
Tumor necrosis factor
TRAIL
Tumor necrosis factor-related apoptosis-inducing ligand
TRAIL-R1–R4
TRAIL receptor 1–4

Authors’ contributions

Authors’ contributions

JL and SLee conceived the study, participated in all experiments, and revised the manuscript. CYL, HHS, and SS participated in in-vitro and in-vivo testing. JWC and SWK participated in in-vitro testing and made significant contribution to revising the manuscript. JCP participated in the study design and provided technical assistance. SLim and KCH conceived the study, participated in the study design, and drafted and edited the manuscript. All authors read and approved the final manuscript.

Notes

Ethics approval and consent to participate

Not applicable.

Consent for publication

All authors declare their support for the publication and its contents.

Competing interests

The authors declare that they have no competing interests.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Footnotes

Electronic supplementary material

The online version of this article (doi:10.1186/s13287-017-0647-6) contains supplementary material, which is available to authorized users.

Contributor Information

Jiyun Lee, ca.shuy@21eelyj.

Seahyung Lee, rk.ca.hsi@7101mas.

Chang Youn Lee, moc.liamg@380eelyc.

Hyang-Hee Seo, ca.shuy@71hhs.

Sunhye Shin, moc.revan@3405hss.

Jung-Won Choi, ten.muad@ainedrag.

Sang Woo Kim, rk.ca.hsi@8047rotcod.

Jong-Chul Park, ca.shuy@cjkrap.

Soyeon Lim, rk.ca.ukc@427mils.

Ki-Chul Hwang, rk.ca.ukc@gnawhck.

References

1. Rasmussen JG, Frobert O, Holst-Hansen C, Kastrup J, Baandrup U, Zachar V, et al. Comparison of human adipose-derived stem cells and bone marrow-derived stem cells in a myocardial infarction model. Cell Transplant. 2014;23(2):195–206. doi: 10.3727/096368912X659871. [PubMed] [Cross Ref]
2. Paul A, Srivastava S, Chen G, Shum-Tim D, Prakash S. Functional assessment of adipose stem cells for xenotransplantation using myocardial infarction immunocompetent models: comparison with bone marrow stem cells. Cell Biochem Biophys. 2013;67(2):263–73. doi: 10.1007/s12013-011-9323-0. [PubMed] [Cross Ref]
3. Burdon TJ, Paul A, Noiseux N, Prakash S, Shum-Tim D. Bone marrow stem cell derived paracrine factors for regenerative medicine: current perspectives and therapeutic potential. Bone Marrow Res. 2011;2011:207326. doi: 10.1155/2011/207326. [PMC free article] [PubMed] [Cross Ref]
4. Song SW, Kim KE, Choi JW, Lee CY, Lee J, Seo HH, et al. Proteomic analysis and identification of paracrine factors in mesenchymal stem cell-conditioned media under hypoxia. Cell Physiol Biochem. 2016;40(1–2):400–10. doi: 10.1159/000452555. [PubMed] [Cross Ref]
5. Hsiao ST, Asgari A, Lokmic Z, Sinclair R, Dusting GJ, Lim SY, et al. Comparative analysis of paracrine factor expression in human adult mesenchymal stem cells derived from bone marrow, adipose, and dermal tissue. Stem Cells Dev. 2012;21(12):2189–203. doi: 10.1089/scd.2011.0674. [PMC free article] [PubMed] [Cross Ref]
6. Hwang HJ, Chang W, Song BW, Song H, Cha MJ, Kim IK, et al. Antiarrhythmic potential of mesenchymal stem cell is modulated by hypoxic environment. J Am Coll Cardiol. 2012;60(17):1698–706. doi: 10.1016/j.jacc.2012.04.056. [PubMed] [Cross Ref]
7. Corallini F, Celeghini C, Rimondi E, di Iasio MG, Gonelli A, Secchiero P, et al. Trail down-regulates the release of osteoprotegerin (OPG) by primary stromal cells. J Cell Physiol. 2011;226(9):2279–86. doi: 10.1002/jcp.22564. [PubMed] [Cross Ref]
8. Emery JG, McDonnell P, Burke MB, Deen KC, Lyn S, Silverman C, et al. Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL. J Biol Chem. 1998;273(23):14363–7. doi: 10.1074/jbc.273.23.14363. [PubMed] [Cross Ref]
9. Wang S, El-Deiry WS. TRAIL and apoptosis induction by TNF-family death receptors. Oncogene. 2003;22(53):8628–33. doi: 10.1038/sj.onc.1207232. [PubMed] [Cross Ref]
10. Buneker C, Mohr A, Zwacka RM. The TRAIL-receptor-1: TRAIL-receptor-3 and -4 ratio is a predictor for TRAIL sensitivity of cancer cells. Oncol Rep. 2009;21(5):1289–95. [PubMed]
11. Fu J, Gao J, Pi R, Liu P. An optimized protocol for culture of cardiomyocte from neonatal rat. Cytotechnology. 2005;49:109–16. doi: 10.1007/s10616-006-6334-6. [Cross Ref]
12. Gough DR, Cotter TG. Hydrogen peroxide: a Jekyll and Hyde signalling molecule. Cell Death Dis. 2011;2:e213. doi: 10.1038/cddis.2011.96. [PMC free article] [PubMed] [Cross Ref]
13. Gille JJ, Joenje H. Cell culture models for oxidative stress: superoxide and hydrogen peroxide versus normobaric hyperoxia. Mutat Res. 1992;275(3–6):405–14. doi: 10.1016/0921-8734(92)90043-O. [PubMed] [Cross Ref]
14. Watkins SJ, Borthwick GM, Arthur HM. The H9C2 cell line and primary neonatal cardiomyocyte cells show similar hypertrophic responses in vitro. In Vitro Cell Dev Biol Anim. 2011;47(2):125–31. doi: 10.1007/s11626-010-9368-1. [PubMed] [Cross Ref]
15. Zafarullah M, Li WQ, Sylvester J, Ahmad M. Molecular mechanisms of N-acetylcysteine actions. Cell Mol Life Sci. 2003;60(1):6–20. doi: 10.1007/s000180300001. [PubMed] [Cross Ref]
16. Cornelissen M, Philippe J, De Sitter S, De Ridder L. Annexin V expression in apoptotic peripheral blood lymphocytes: an electron microscopic evaluation. Apoptosis. 2002;7(1):41–7. doi: 10.1023/A:1013560828090. [PubMed] [Cross Ref]
17. Pardali E, Ten Dijke P. TGFbeta signaling and cardiovascular diseases. Int J Biol Sci. 2012;8(2):195–213. doi: 10.7150/ijbs.8.195. [PMC free article] [PubMed] [Cross Ref]
18. Ashkenazi A, Dixit VM. Apoptosis control by death and decoy receptors. Curr Opin Cell Biol. 1999;11(2):255–60. doi: 10.1016/S0955-0674(99)80034-9. [PubMed] [Cross Ref]
19. Jeremias I, Kupatt C, Martin-Villalba A, Habazettl H, Schenkel J, Boekstegers P, et al. Involvement of CD95/Apo1/Fas in cell death after myocardial ischemia. Circulation. 2000;102(8):915–20. doi: 10.1161/01.CIR.102.8.915. [PubMed] [Cross Ref]
20. Braunersreuther V, Jaquet V. Reactive oxygen species in myocardial reperfusion injury: from physiopathology to therapeutic approaches. Curr Pharm Biotechnol. 2012;13(1):97–114. doi: 10.2174/138920112798868782. [PubMed] [Cross Ref]
21. Kalogeris T, Baines CP, Krenz M, Korthuis RJ. Cell biology of ischemia/reperfusion injury. Int Rev Cell Mol Biol. 2012;298:229–317. doi: 10.1016/B978-0-12-394309-5.00006-7. [PMC free article] [PubMed] [Cross Ref]
22. Sugamura K, Keaney JF., Jr Reactive oxygen species in cardiovascular disease. Free Radic Biol Med. 2011;51(5):978–92. doi: 10.1016/j.freeradbiomed.2011.05.004. [PMC free article] [PubMed] [Cross Ref]
23. Webster KA. Mitochondrial membrane permeabilization and cell death during myocardial infarction: roles of calcium and reactive oxygen species. Future Cardiol. 2012;8(6):863–84. doi: 10.2217/fca.12.58. [PMC free article] [PubMed] [Cross Ref]

Articles from Stem Cell Research & Therapy are provided here courtesy of BioMed Central